Antibody persistence and safety 3 years after CYD tetravalent dengue vaccination: follow-up results from a phase I trial in the Philippines
Author(s) -
María Rosario Capeding,
Anh Wartel,
Mark Boaz,
Thelma Laot,
Denis Crevat
Publication year - 2012
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2012.05.984
Subject(s) - dengue fever , medicine , dengue vaccine , vaccination , immunogenicity , titer , neutralizing antibody , regimen , antibody , immunology , virology , dengue virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom